Cord serum brain-derived neurotrophic factor levels at birth associate with temperament outcomes at one year.


Journal

Journal of psychiatric research
ISSN: 1879-1379
Titre abrégé: J Psychiatr Res
Pays: England
ID NLM: 0376331

Informations de publication

Date de publication:
06 2022
Historique:
received: 04 11 2021
revised: 31 01 2022
accepted: 04 03 2022
pubmed: 31 3 2022
medline: 18 5 2022
entrez: 30 3 2022
Statut: ppublish

Résumé

Altered serum levels of brain-derived neurotrophic factor (BDNF) are consistently linked with neurological disorders. BDNF is also increasingly implicated in the pathogenesis of neurodevelopmental disorders, particularly those found more frequently in males. At birth, male infants naturally have significantly lower serum BDNF levels (∼10-20% lower than females), which may render them more vulnerable to neurodevelopmental disorders. We previously characterized serum BDNF levels in mothers and their newborn infants as part of the Grown in Wales Study. Here, we analyzed whether cord serum BDNF levels at birth correlate with sex-specific outcomes at one year. The Bayley Scale of Infant Development, Third Edition (BSID-III) and Laboratory Temperament Assessment Battery (Lab-TAB) tasks were used to assess infant behavior and neurodevelopment at 12-14 months (mean ± SD: 13.3 ± 1.6 months; 46% male; n = 56). We found no relationship between serum BDNF levels at birth and BSID-III neurodevelopmental outcomes (cognitive or language), nor with infant behaviors in the Lab-TAB unpredictable mechanical toy or maternal separation tasks. In the sustained attention task, there was a significant positive relationship between serum BDNF and infant negative affect (B = 0.06, p = 0.018) and, for boys only, between serum BDNF and intensity of facial interest (B = 0.03, p = 0.005). However, only the latter remained after correction for multiple testing. This sex-specific association between cord serum BDNF and a parameter of attention at 12-14 months provides some support for the hypothesis that reduced serum BDNF levels at birth are linked to an increased risk for neurodevelopmental disorders.

Identifiants

pubmed: 35354099
pii: S0022-3956(22)00131-5
doi: 10.1016/j.jpsychires.2022.03.009
pmc: PMC9225956
pii:
doi:

Substances chimiques

Brain-Derived Neurotrophic Factor 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

47-53

Subventions

Organisme : Medical Research Council
ID : MR/N013794/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M009122/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M013960/1
Pays : United Kingdom

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Brain Behav Immun. 2020 Aug;88:105-113
pubmed: 32418647
J Biol Chem. 2016 May 6;291(19):9872-81
pubmed: 27006395
Psychoneuroendocrinology. 2016 Dec;74:69-76
pubmed: 27588702
Mol Psychiatry. 2014 Jul;19(7):791-800
pubmed: 23958957
Biol Psychiatry. 2008 Sep 15;64(6):527-32
pubmed: 18571629
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1824-8
pubmed: 18760321
Eur Child Adolesc Psychiatry. 2014 Mar;23(3):173-7
pubmed: 23812866
Toxicol Sci. 2010 Oct;117(2):263-9
pubmed: 20631062
CNS Neurol Disord Drug Targets. 2019;18(6):496-501
pubmed: 31269890
Eur Child Adolesc Psychiatry. 2017 Mar;26(3):355-363
pubmed: 27561780
J Exerc Nutrition Biochem. 2017 Sep 30;21(3):35-42
pubmed: 29036764
Neurosci Lett. 2002 Aug 16;328(3):261-4
pubmed: 12147321
Front Endocrinol (Lausanne). 2021 Jun 01;12:653095
pubmed: 34140927
J Affect Disord. 2020 Mar 1;264:383-392
pubmed: 32056774
Transl Psychiatry. 2021 Jan 18;11(1):62
pubmed: 33462179
Mol Endocrinol. 2001 Oct;15(10):1748-57
pubmed: 11579207
J Neuroimmune Pharmacol. 2017 Sep;12(3):531-543
pubmed: 28405874
Int J Psychiatry Clin Pract. 2014 Oct;18(4):280-7
pubmed: 24994482
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:20-4
pubmed: 23933054
Psychopharmacology (Berl). 2014 Apr;231(7):1389-95
pubmed: 24202115
J Exerc Nutrition Biochem. 2015 Jun;19(2):115-21
pubmed: 26244130
Psychoneuroendocrinology. 2016 Jan;63:191-7
pubmed: 26460781
Int J Neuropsychopharmacol. 2013 Jan 30;16(6):1267-1275
pubmed: 23363778
Dialogues Clin Neurosci. 2002 Sep;4(3):287-93
pubmed: 22034090
J Neurochem. 1999 May;72(5):1930-8
pubmed: 10217270
Environ Res. 2015 Oct;142:602-8
pubmed: 26301740
Psychiatry Res. 2014 Jul 30;217(3):191-7
pubmed: 24713358
JAMA Pediatr. 2016 Nov 1;170(11):1079-1086
pubmed: 27654278
Front Psychol. 2017 May 24;8:846
pubmed: 28596748
Pharmacol Res. 2010 Dec;62(6):523-9
pubmed: 20691787
Psychiatry Res. 2002 Mar 15;109(2):143-8
pubmed: 11927139
Brain Sci. 2021 Apr 21;11(5):
pubmed: 33919004
J Pediatr. 2020 Nov;226:71-79.e5
pubmed: 32610169
Acta Psychiatr Scand. 2016 Sep;134(3):268-74
pubmed: 27209073
Transl Psychiatry. 2019 Oct 7;9(1):252
pubmed: 31591381
Pediatr Res. 2003 Jun;53(6):965-9
pubmed: 12621105
Nord J Psychiatry. 2019 May - Jul;73(4-5):302-307
pubmed: 31170860
Psychoneuroendocrinology. 2017 May;79:31-39
pubmed: 28249186
Mol Psychiatry. 2003 Nov;8(11):898-9
pubmed: 14593425
EMBO J. 2000 Mar 15;19(6):1290-300
pubmed: 10716929
Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 5;144B(4):574-7
pubmed: 17427191
Front Psychiatry. 2018 Jan 17;8:308
pubmed: 29387021
J Child Psychol Psychiatry. 2015 Mar;56(3):228-47
pubmed: 25266278
Noro Psikiyatr Ars. 2016 Dec;53(4):348-352
pubmed: 28360811
Arch Gynecol Obstet. 2017 Aug;296(2):205-213
pubmed: 28589478
Pediatr Pulmonol. 2019 Mar;54(3):303-312
pubmed: 30575339
J Clin Med. 2019 Sep 02;8(9):
pubmed: 31480710
Int J Neuropsychopharmacol. 2008 Dec;11(8):1169-80
pubmed: 18752720
Nat Rev Neurosci. 2013 Jan;14(1):7-23
pubmed: 23254191
Psychopharmacology (Berl). 2017 Jan;234(2):267-279
pubmed: 27807606
Pediatr Neonatol. 2021 May;62(3):298-304
pubmed: 33753004
Int J Neuropsychopharmacol. 2011 Apr;14(3):347-53
pubmed: 20604989
Environ Pollut. 2016 Apr;211:67-73
pubmed: 26736057
Protein Expr Purif. 1995 Aug;6(4):465-71
pubmed: 8527932
Sci Rep. 2021 Jan 8;11(1):15
pubmed: 33420109
Chemosphere. 2016 Nov;163:446-451
pubmed: 27565312
Arch Dis Child Educ Pract Ed. 2021 Apr;106(2):108-112
pubmed: 32859738
Mol Neurobiol. 2019 May;56(5):3295-3312
pubmed: 30117106
Child Adolesc Psychiatry Ment Health. 2016 May 19;10:10
pubmed: 27200107
Sci Rep. 2020 Oct 15;10(1):17348
pubmed: 33060610
Int J Mol Sci. 2019 Jan 10;20(2):
pubmed: 30634650
J Exp Child Psychol. 2019 Aug;184:192-209
pubmed: 31039447
Med Hypotheses. 2003 Jun;60(6):849-51
pubmed: 12699711
Eur Child Adolesc Psychiatry. 2018 Jan;27(1):127-135
pubmed: 28710695
Biol Psychiatry. 2008 Nov 1;64(9):797-802
pubmed: 18486103
J Affect Disord. 2015 Mar 15;174:432-40
pubmed: 25553404
PLoS One. 2016 Aug 04;11(8):e0160455
pubmed: 27489945
eNeuro. 2018 Mar 22;5(2):
pubmed: 29662942

Auteurs

Hayley Dingsdale (H)

School of Biosciences, Cardiff University, Cardiff, CF10 3AX, UK.

Samantha M Garay (SM)

School of Biosciences, Cardiff University, Cardiff, CF10 3AX, UK.

Hannah R Tyson (HR)

School of Biosciences, Cardiff University, Cardiff, CF10 3AX, UK.

Katrina A Savory (KA)

School of Biosciences, Cardiff University, Cardiff, CF10 3AX, UK.

Lorna A Sumption (LA)

School of Biosciences, Cardiff University, Cardiff, CF10 3AX, UK.

Jemima S Kelleher (JS)

School of Biosciences, Cardiff University, Cardiff, CF10 3AX, UK.

Kate Langley (K)

School of Psychology, Cardiff University, Cardiff, CF10 3AT, UK.

Stephanie Van Goozen (S)

Cardiff University Centre for Human Developmental Science, School of Psychology, Cardiff University, Cardiff, CF10 3AT, UK.

Rosalind M John (RM)

School of Biosciences, Cardiff University, Cardiff, CF10 3AX, UK. Electronic address: JohnRM@cardiff.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH